drugset / Trial / NCT02168738
Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to compare three lipidic forms of DHA in their metabolic pathway in human by using 13C labeled molecules. The circulating form of DHA plays a major role in his cerebral incorporation. The aim of this research is to confirm that some lipidic forms are best carriers for the cerebral incorporation in studying 13C-DHA distribution in plasma lipids and blood cells.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AceDoPC | Other / unclassified | 50 mg | Oral |
| Subject | PC-DHA | Other / unclassified | 50 mg | — |
| Subject | TG-DHA | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.